Clinical trials

  • PEMBROLIZUMAB for Breast cancer|Inflammatory breast cancer|HER2-negative breast cancer
  • FLUOROURACIL for Head and neck squamous cell carcinoma (recurrent or metastatic) | PD-L1-positive
  • RIBOCICLIB for Hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer
  • DMD06-MAB for Duchenne muscular dystrophy
  • alfentanil hydrochloride for Severe acute pain
  • Clinical trial in Obesity|Right heart failure
  • HUMAN NORMAL IMMUNOGLOBULIN for COVID-19|Severely impaired B-cell function
  • ADALIMUMAB for Folliculitis decalvans
  • pembrolizumab for Sarcoma | Melanoma | Triple-negative breast cancer | Colorectal cancer | Non-small cell lung cancer
  • Atumelnant for Congenital adrenal hyperplasia
  • TALETRECTINIB for Non-small cell lung cancer
  • ENSIFENTRINE for Non-Cystic Fibrosis Bronchiectasis